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Objective To assess the relationship between the ethnicity of
women and the clinical success of in vitro fertilisation (IVF) or
intracytoplasmic sperm injection (ICSI) treatment.
Design Observational cohort study.
Setting Nottingham University Research and Treatment Unit in
Reproduction (NURTURE), UK.
Sample A total of 1517 women, of which 1291 were white
Europeans and 226 belonged to an ethnic minority group. All the
women were undergoing their first cycle of assisted reproductive
technology (ART) between 2006 and 2011.
Methods All of the women underwent their first cycle of ART
between 2006 and 2011.
Main outcome measures Live birth rates following IVF or ICSI
treatment.
Results Although pre-treatment ovarian reserve variables [mean
age, basal follicle stimulating hormone (FSH), and total antral
follicle count] were significantly favourable in the ethnic group,
the live birth rates were significantly lower in this group (35%)
compared with the white European group (43.8%) (relative risk
0.8; 95% CI 0.66–0.97). On logistic regression analysis, ethnicity
was an independent predictor of live birth rate (OR 0.688; 95%
CI 0.513–0.924). After controlling for the other independent
variables (age and FSH), the significant association between
ethnicity and live birth rate remained strong (OR 0.591; 95% CI
0.425–0.822) on multivariate logistic regression analysis.
Conclusions Live birth rates following IVF or ICSI treatment were
significantly lower in the ethnic minority group compared with
white European women, which suggests that ethnicity is a major
determinant of live birth following IVF treatment.
Keywords ART births, assisted conception, embryo, ethnic
background, ICSI, infertility, IVF.
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Introduction
In the western world, ethnic minorities form a significant
proportion of couples undergoing in vitro fertilisation
(IVF) treatment. Whereas couples should be informed of
their realistic chances of success based on data applicable
to their own individual status, the data on the relationship
between ethnicity and IVF outcome is limited. In the litera-
ture, a scarce number of reports were published on the
relationship between ethnic background and IVF outcome.
Self-identified Asian infertile women in the USA were
reported to have lower clinical pregnancy and live birth
rates compared with white women.1 Other authors in the
USA have also reported that white women had more bio-
chemical pregnancies and live birth rates compared with
women from ethnic minorities, including Hispanic, Asian
and Afro-Caribbean women.2–7
In the UK, two studies that were published in the mid
and late 1990s reported differing observations in relation to
women of South Asian Indian background undergoing IVF
compared with white European populations.8,9 In two sep-
arate studies, again in the USA, lower live birth rates were
reported in South Asian Indian women compared with
white women, despite their younger age and lower basal
follicle stimulating hormone (FSH) levels.10,11 Less than a
handful of studies reported no differences in assisted
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reproductive technology (ART) outcome between Hispanic
and white women,12 or between African-American and
white women.13,14 In a separate Spanish study using oocyte
donation, differences in ART outcome were reported
between black and white European women, but no differ-
ence was observed between South-East Asian and white
European women15; however, no live birth data were
reported. Whereas large studies, mostly from the USA,
reported an association between race/ethnicity and ART
outcome,16 studies from outside the USA, especially from
the UK, have reported conflicting results. The latter studies
are mostly of small sample size and are more than a decade
old, when success rates were lower compared with current
success rates.
In this current study, we aimed to investigate the relation-
ship between ethnicity and IVF outcome in a large IVF pop-
ulation receiving treatment over a period of 5 years between
2006 and 2011. The IVF outcome, including live birth rates
between ethnic minority and white European groups, were
compared. The different ethnic minorities were further
subcategorised, and the differences in outcome between the
subpopulation groups, such as South-East Asian, Afri-
can-Caribbean, and Middle Eastern, were also studied.
Methods
Experimental design
In this observational cohort study we aimed to recruit all
women undergoing their first cycle of IVF or intracytoplas-
mic sperm injection (ICSI) treatment. This study was per-
formed in the UK at the Nottingham University Research
and Treatment Unit in Reproduction (NURTURE), and
included all women who met the above criterion between
2006 and 2011. All of them were undergoing their first
cycle of ART. All couples were asked to complete their
demographic profile, including their ethnic origin, follow-
ing the policy of the unit. White women were identified as
white Europeans. Other ethnic groups undergoing treat-
ment were South-East Asians (from India, Pakistan, Ban-
gladesh, and Sri Lanka), Middle-Eastern Asians, and
African-Caribbeans. The study was approved by the institu-
tional review board. The process of data extraction was
consistent with the data protection rules.
Treatment protocol
All participants underwent IVF/ICSI treatment using a stan-
dard long agonist or antagonist protocol, depending on
ovarian reserve tests, as previously described.17 For the long
protocol, down-regulation with gonadotrophin-releasing
hormone (GnRH) agonists [500 lg/day of buserelin
(Suprefact; Aventis Pharma, Kent, UK) or 800 lg/day of
nafarelin (Synarel; Pharmacia, Milton Keynes, UK)] was
started in the midluteal phase of the menstrual cycle. Pitui-
tary desensitisation was confirmed 2 weeks later by an endo-
metrial thickness of less than 5 mm and no ovarian activity
evident on transvaginal ultrasound, in association with an
estradiol level <200 pmol/L; ovarian stimulation was then
commenced. In an antagonist protocol, ovarian stimulation
is commenced on day 2 of the menstrual cycle by introduc-
ing antagonists (0.25 mg of cetrorelix; Cetrotide [cetrolix
acetate for injection, Merck Serono Pharmaceuticals Ltd,
Feltham, UK]) from day 5 of ovarian stimulation. The start-
ing daily doses of gonadotrophins [recombinant FSH
(rFSH) or human menopausal gonadotrophins (HMGs)
were 150–450 iu, depending on the woman’s age and ovar-
ian reserve test.
The women were monitored for follicular development
by a series of transvaginal ultrasound and serum estradiol
measurements from the fifth or sixth day of stimulation.
When there were three follicles measuring 18 mm or more
in diameter, human chorionic gonadotrophin [hCG;
6500 iu Ovitrelle (Merck Serono Pharmaceuticals Ltd,
Feltham, UK) or 10 000 iu of Pregnyl (Organon Labora-
tories Ltd, Cambridgeshire, UK] was administered, and
oocyte retrieval was performed 36 hours later. Transvaginal
ultrasound-guided oocyte retrieval was performed under
sedation or general anaesthesia. The oocytes retrieved were
fertilised by IVF or ICSI treatment, depending on the
results of the semen analysis or the quality of the semen
obtained on the day of oocyte retrieval. For women with
partners considered to have normal semen parameters, IVF
was performed by mixing groups of collected oocytes with
a sperm suspension containing 150 000 motile sperm/ml
overnight in the incubator. For women having ICSI, mei-
otic maturity was assessed after denudation and only
mature oocytes with a visible polar body were injected with
one sperm following its mechanical immobilisation. Fertili-
sation as determined by the presence of two pronuclei
(2 PN) was assessed at 18–20 hours after IVF or ICSI.
Depending on the number of embryos that develop, a max-
imum of two embryos were transferred into the uterus at
days 2, 3, or 5 after insemination by IVF or ICSI. Single
embryo transfer was discussed with the women and offered
in line with the normal practice of the clinic. From the day
of embryo transfer, luteal phase support was started using
progesterone pessaries (400 mg twice a day vaginally; Cy-
clogest; Shire Pharmaceuticals Ltd, Basingstoke, Hants,
UK), and the serum hCG level was measured 16 days later
to determine the outcome (biochemical pregnancy). A
transvaginal ultrasound was arranged 3–4 weeks later to
confirm the viability of the pregnancy (clinical pregnancy)
if the biochemical test was positive (hCG > 50 iu/L). A
repeat ultrasound scan was also performed at 12 weeks of
gestation to ensure that the pregnancy remained viable
(continuing pregnancy). All pregnant women were fol-
lowed-up to know the eventual outcome of their
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pregnancies, and a live birth is thus defined as a viable
infant born after 24 weeks of gestation. The miscarriage
rate is calculated as the proportion of pregnancies lost
before 24 weeks of gestation.
Statistical analysis
Data recorded in a Microsoft EXCEL spreadsheet were analy-
sed using SPSS 16 for WINDOWS (Statistical Package for Social
Sciences; IBM, Chicago, IL, USA). The primary outcome
was live birth. Secondary outcomes included clinical preg-
nancy rates, implantation rates, and ovarian response, as
measured by the number of oocytes retrieved. The Levene
test of homogeneity of variances and Kolmogorov–Smirnov
test of normality were performed to choose the appropriate
statistical test. Continuous data were analysed by a Stu-
dent’s t–test or by the Mann–Whitney U–test, depending
on the data distribution. Chi-square and Fisher exact tests
were performed to analyse the relationship between two
categorical variables. When P < 0.05, the difference was
considered to be statistically significant in all statistical
tests. Logistic regression analysis was used to assess the
association of ethnicity and other demographic variables
with live birth rates. To estimate the independent contribu-
tion of ethnic minority group to treatment outcomes, mul-
tivariate logistic regression analyses were performed.
Potential confounding factors found to be statistically sig-
nificant in univariate analyses and others generally regarded
as clinically significant were included in the models. Back-
ward conditional elimination was used to generate the
most parsimonious model.
Results
Of the 1517 women who began ovarian stimulation treat-
ment, 23 did not reach the egg-collection stage because of
poor ovarian response, 11 developed an excessive response,
and therefore embryo transfer was deferred, with the freez-
ing of all embryos to reduce the risk of severe ovarian hy-
perstimulation syndrome (OHSS), five had no eggs
collected at the oocyte retrieval stage, nine had no mature
eggs, and therefore could not proceed with ICSI treatment,
39 had failed fertilisation, and 35 had failed cleavage or
failed development of blastocysts. Eventually, 1395 women
had embryo transfer.
Analysis was performed in a total of 1517 women, of
which 1291 (85.1%) were white Europeans and 226
(14.9%) belonged to an ethnic minority group. Table 1
illustrates a comparison of the clinical, endocrine, and
ultrasound variables between the two groups. Whereas
pre-treatment ovarian reserve variables (mean age, basal
FSH, and total antral follicle count) were significantly
favourable in the ethnic group (Table 1), the stimulation
characteristics (dose of gonadotrophins and duration of
stimulation) and embryology data (number of eggs
retrieved, fertilisation and cleavage rates, single and double
embryo transfer rates, and blastocyst transfer rates) were
similar in both groups (Table 2). However, the live birth
rates were significantly lower in the ethnic minority group,
as were the biochemical pregnancy rates, clinical pregnancy
rates, and implantation rates (Figure 1A; Table 2). All these
outcomes were calculated per cycle started.
Table 1. Comparison of baseline clinical, endocrine, and ultrasound characteristics between ethnic and white European groups (data presented as
 SD and range or%)
Variables Ethnic group
(n = 226)
White European group
(n = 1291)
P
Age 33.3  4.5 (23–44) 34.4  4.3 (21–45) <0.001
Body mass index (kg/m²) 25.8  4.2 (17.0–35.0) 24.3  3.5 (18.0–36.0) <0.001
Basal FSH (iu/L) 6.0  2.4 (0.1–14.2) 6.6  2.5 (0.9–14.9) <0.01
Cause of infertility
Male 92 (40.5%) 441 (34.2%) <0.02
Female 57 (25.1%) 447 (34.6%)
Combined 40 (17.7%) 152 (11.8%)
Unexplained 37 (16.7%) 251 (19.4%)
Type of infertility
Primary 179 (71.9%) 932 (72.2%) 0.924
Secondary 64 (28.1%) 359 (27.8%)
Smoking
Non–smoker 223 (98.6%) 1180 (91.4%) <0.001
Smoker 3 (1.4%) 111 (8.6%)
Duration of infertility (months) 50.5  36.5 (10–246) 42  26.7 (2–240) <0.001
Total antral follicle count 20.4  12.4 (1–77) 17.7  9.8 (3–91) <0.01
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On univariate logistic regression analysis, ethnicity was
an independent predictor of live birth rate (OR 0.688;
95% CI 0.513–0.924; P ≤ 0.02). Age and FSH were the
other independent predictors of live birth among all the
variables studied (Table 3). On multivariate analysis incor-
porating age, FSH, and ethnicity, after controlling for age
and FSH, ethnicity remained as a significant predictor of
live birth (OR 0.591; 95% CI 0.425–0.822; P ≤ 0.01;
Table 3), with its association strengthened further as
indicated by a shift of odds ratio from 0.688 to 0.591.
Within the ethnic minority group, three distinct sub-
groups were identified: South-East Asian (n = 182); Afri-
can-Caribbean (n = 30); and Middle Eastern (n = 14). The
live birth rates in the South-East Asian, African-Caribbean,
and Middle-Eastern populations were 38% (69/182), 23.3%
(7/30), and 21.4% (3/14), respectively, in contrast to the
live birth rates in the white European population (43.8%;
566/1291; Figure 1A,B). A pairwise comparison revealed
similar live birth rates between the subgroups and white
European population, although there was a trend towards
decreased live birth rate in ethnic minority groups, particu-
larly in the African-Caribbean and Middle-Eastern Asian
populations. The relative risks for the South-East Asian,
African-Caribbean, and Middle-Eastern populations were
0.86 (95% CI 0.71–1.05; P = 0.15), 0.53 (95% CI 0.28–
1.02; P = 0.06), and 0.49 (95% CI 0.18–1.34; P = 0.16),
respectively. On regression analysis, ethnicity was not a sig-
nificant predictor of successful IVF outcome (live birth)
when only the South-East Asian population (a single large
ethnic minority group) was included in the analysis
(OR 0.78; 95% CI 0.57–1.08).
Discussion
Main findings
The data in this study indicate that live birth rates, clinical
pregnancy rates, and implantation rates following IVF
treatment are significantly lower in the ethnic group com-
pared with white European women, and it proves that eth-
nicity may be a major determinant of live birth following
IVF treatment. Upon subgroup analysis, the success rates
were lower in the South-East Asian, African-Caribbean, and
Middle-Eastern populations, in descending order; however,
the live birth rates in these different subgroups were not
statistically different from the live birth rates in the white
European population, possibly because of the small sample
sizes of each subgroup. In this work we tried to narrow
down the category of the Asian population to South-East
Asians and Middle-Eastern Asians so that the analysis
reflects a more homogeneous population, who are more
likely to respond uniformly to ART treatment.
Strengths and limitations
As this study used a consecutive unselected population,
there were differences observed in the demographic profile
between the groups with most factors (age, smoking status,
Table 2. Mean  SD (range) values for the stimulation characteristics, embryology data, and outcome variables
Variables Ethnic group
(n = 226)
White European group
(n = 1291)
P
Starting daily dose of gonadotrophins 247  109.8 (75–450) 245.7  68.5 (75–450) 0.828
Total dose of gonadotrophins used 2896.3  1905.3 (750–6300) 2733.8  1306.2 (900–7500) 0.178
Peak estradiol level (pmol/L) 7933  4634.6 (11–21834) 7883.9  5319.7 (79–74063) 0.906
Number of follicles aspirated 14.2  7.6 (0–40) 14.5  8.5 (0–59) 0.587
Number oocytes retrieved 11.5  7.3 (0–50) 11.4  6.4 (0–58) 0.777
Number of mature oocytes 9.4  5.9 (0–35) 9.5  5.5 (0–49) 0.771
Fertilisation rate (%) 63.3  27.2 66  25.1 0.147
Cleavage rate (%) 95.7  14.9 95.7  13.2 0.966
Blastocyst rate (%) 40.2  18.7 42.9  21.9 0.466
Number of embryos transferred
1 66 (32.4%) 414 (34.8%) 0.656
2 138 (67.6%) 777 (65.2%)
Days of embryo transfer
2 or 3 days 166 (81.4%) 936 (78.6%) 0.367
5 days 38 (18.6%) 255 (21.4%)
Over all implantation rate* 22.6% 37.4% <0.01
Biochemical pregnancy rate 97 (42.9%) 712 (55.2%) 0.001
Clinical pregnancy rate 87 (38.5%) 619 (47.9%) 0.009
Live birth rate 79 (35.0%) 566 (43.8%) 0.013
*Implantation rate is measured as the number of fetal hearts measured over the number of embryos transferred.
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and antral follicle count), favouring the ethnic minority
groups. Despite this, IVF/ICSI success rates were lower in
the ethnic minority group. Besides using a consecutive
unselected population analysed only for the first treatment
cycle, another major strength of our study is that we have
reported on live birth rates rather than just the pregnancy
rates. The major aim of all couples undergoing any fertility
treatment is to achieve a healthy baby, and the results from
this study will help us to counsel couples from the ethnic
minority groups appropriately, as their success rates may
match the overall success rate of the unit. Furthermore,
our study population, with 85.1% white Europeans and
14.9% from ethnic minorities, reflects the typical UK popu-
lation (85.4% white Europeans and 14.6% ethnic minori-
ties), according to the Office for National Statistics in the
UK.18 Although the sample size of the South-East Asian
population (n = 182) in our study was moderate, the cor-
responding sizes of the African-Caribbean (n = 30) and
Middle-Eastern (n = 14) populations were very small for
providing meaningful data on subgroup analysis for coun-
selling women from those ethnic backgrounds, and a larger
data set is needed for this purpose.
Interpretations
The data in this study agree with most other publications,
and notably with the work by Purcell and colleagues
reporting a significantly low live birth rate compared with
the white population in the USA.1 Although this study
reported results for the Asian population as a whole, we
have also individually reported the results for the South-
East Asian and Middle-Eastern Asian populations sepa-
rately. Whereas there are other reports comparing success
rates in South-East Asian and white populations in the
UK,2,8,9,19 two have reported significantly lower pregnancy
rates in the South-East Asian population,9,19 with the other
two reporting similar pregnancy rates.2,8 Whereas the study
by Palep-Singh et al.19 exclusively looked at a selected pop-
ulation with polycystic ovary syndrome (PCOS), the other
studies reported on smaller sample sizes. In contrast, our
study used unselected women with a larger sample size,
and included only the first cycle of IVF/ICSI treatment,
which would have limited potential selection and treatment
bias.
Observed differences of treatment outcome in the ethnic
minority group may be reflective of true biological differ-
ences, which may primarily be related to lifestyle factors,
socio-economic statuse, or some unknown factors.
Whereas genetic background is a potential determinant of
quantitative and qualitative ovarian reserve, and subse-
quent IVF outcome, variation in environmental exposures
and lifestyle and cultural factors could be influencing the
reproductive outcomes. It is interesting to note that ovar-
ian response, as assessed by the number of oocytes
retrieved, and peak estradiol levels, fertilisation rate,
embryo cleavage rate, blastocyst development rate, and the
number of embryos transferred were similar between the
ethnic and white European groups. However, the implan-
tation rate was significantly lower in the ethnic minority
group, and this was consequently reflected in the live birth
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Figure 1. Live birth rates (LBRs): (A) white European women versus
women from all ethnic minorities (P = 0.013); (B) white European
women versus women from South-East Asian, African-Caribbean, and
Middle-Eastern Asian groups.
Table 3. Logistic regression analysis of the baseline characteristics,
for the prediction of live birth.
Parameters Odds ratio 95% CI P
Univariate analysis
Age 0.937 0.915–0.959 <0.001
Body mass index (kg/m2) 0.977 0.940–1.017 0.254
Basal FSH 0.933 0.881–0.989 <0.02
Smoking 0.605 0.342–1.068 0.083
Duration of infertility 0.997 0.992–1.002 0.259
Total antral follicle count 1.012 0.998–1.026 0.087
Ethnicity 0.688 0.513–0.924 <0.02
Multivariate analysis of all the significant variables of
univariate analysis
Age 0.944 0.915–0.974 <0.001
Basal FSH .939 0.886–0.995 <0.05
Ethnicity 0.591 0.425–0.822 <0.01
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rates. The reason for the reduced implantation rate and
subsequent reduced outcome in the ethnic minority group
is unclear, although this points to a need for further inves-
tigation, specifically into endometrial receptivity. It is
extremely unlikely that genital infections, such as tubercu-
losis, which are more prevalent in Asian and African coun-
tries, may have played a role in the reduced endometrial
receptivity, as most of the ethnic minority population are
first or later generations, and therefore have very limited
exposure to such infections. There may be other reasons,
with an increased prevalence of certain pathologies such as
PCOS and uterine fibroids in the ethnic population, as
these pathologies are known to adversely influence endo-
metrial receptivity. In summary, the strong association
between ethnicity and IVF outcome may be related to vari-
ous factors; however, a true direct causal effect of ethnicity
on IVF outcome is difficult to establish until a large pro-
spective observational study, controlling for lifestyle fac-
tors, socio-economic status, and other possible factors,
including various pelvic pathologies, demonstrates a strong
consistent association.20
Although there is a reduction in live birth rates in the
ethnic minorities compared with their white European
counterparts following IVF treatment, the results are not
favourable for Asians following intrauterine insemination
(IUI) either. In a study on IUI following ovarian stimula-
tion, Lamb et al.21 showed that Asian women had a 2.8%
reduction in pregnancy rate compared with their white
counterparts: 40% of the women who sought treatment
had more than 2 years of infertility, whereas only 26.7% of
white women had a duration of more than 2 years of infer-
tility. Hence Asian women in general should be motivated
to seek treatment earlier to improve their pregnancy rates,
as age is a well-established determinant factor for treatment
outcome. It is reassuring to note that fecundability and
spontaneous conceptions were similar between Asian and
white populations in one study.22 This may indicate that
reproductive physiology and implantation are not different
in natural cycles, in contrast to superovulated and supra-
physiological cycles during ART.
Conclusion
The data in this study indicate that live birth rates, clinical
pregnancy rates, and implantation rates following IVF
treatment are significantly reduced in the ethnic group
compared with white European women, which suggests
that ethnicity is a major determinant of live birth following
IVF treatment. Upon subgroup analysis, success rates
remain lower in the South-East Asian, African-Caribbean,
and Middle-Eastern populations, in descending order, than
in the white European population, but these differences
were not statistically significant, possibly because of the
small sample sizes. Patients undergoing subfertility treat-
ment have various emotions, ranging from hope and cau-
tious optimism to anxiety and frustration. Hence it is
important that women are well informed about their realis-
tic probabilities of a positive outcome with fertility treat-
ment. Meticulous data collection and analysis for each
ethnic group in each fertility unit can help provide appro-
priate counselling to women from ethnic minority groups.
Further research is needed to estimate the degree of varia-
tion in success rates of IVF treatment from a very large
database. Modifications in clinical strategies to bring about
equivalent success rates among all ethnic groups can be
achieved after the relationship between ethnicity and IVF
outcome is better understood.
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Commentary on ‘Effect of ethnicity on live birth rates after
in vitro fertilisation or intracytoplasmic sperm injection
treatment’
Major differences in fertility exist between breeds within the same livestock species. In humans, large variations in sperm
count have been described for different ethnicities. With all the morphometric and genetic variation between ethnic
groups, is it not likely that fertility might also vary significantly between different populations, despite all living humans
belonging to one single species? Would not such variation also affect the chance of live birth after in vitro fertilisation
(IVF) or intracytoplasmic sperm injection (ICSI)?
The setting of a single IVF centre treating infertile couples with different ethnic backgrounds but with a similar envi-
ronmental exposure constitutes a putatively ideal playground to tackle the issue of differences in IVF outcome between
ethnicities. In the current issue of BJOG Jayaprakasan and colleagues report an elaborate analysis of a cohort of 1517
women undergoing their first IVF or ICSI cycles. Within this cohort 1291 (85%) women were classified as white Euro-
pean, whereas 182 (12%), 30 (2%), and 14 (1%) women were classified as being of South-East Asian,
African-Caribbean, and Middle-Eastern origin, respectively. The authors conclude from their analysis that ethnicity is
independently associated with the likelihood of live birth after IVF treatment. The confounding factors assessed were
female age, body mass index (BMI), basal follicle stimulating hormone (FSH), smoking, duration of infertility, and
antral follicle count (AFC).
Observational studies draw inferences about the effect of an exposure on subjects, where the assignment of subjects to
groups is observed rather than manipulated (e.g. randomised). Therefore, observational studies can rarely convincingly
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demonstrate cause-and-effect phenomena because of the issue of confounding. For the critical reader it is therefore man-
datory to always scrutinise the results from observational research to determine whether alternative explanations for the
study results exist.
In the present analysis, differences between groups in socio-economic background, promiscuity, previous genital tract
infections, incidence of genital tuberculosis, drug abuse, consanguinity, number and type of previous (less costly) conser-
vative treatment attempts, etc. are all potential confounding factors of the likelihood of live birth. These confounding
factors could not be assessed. Is it possible that such confounding could – at least partly – also account for the finding
that African-Caribbean and Middle-Eastern women had a much worse outcome compared with South-East Asian and
white European women?
From a methodological point of view it is noteworthy that the sample sizes are not well balanced between the groups
compared, and that the numbers of subjects in the ethnic minority groups are rather small. This prevents the generation
of precise estimates of effect sizes. Accordingly, statistical significance is only achieved when all ethnic minority groups
are pooled as if they were one group, and when the analysis is artificially limited to a single comparison (e.g. all white
European women versus any women from ethnic minorities), despite major differences in outcomes between individual
ethnic groups.
So is belonging to an ethnic minority within an industrialised western European setting indeed causal for worse IVF
outcomes, independent of other anamnestic, socio-economic, and general health factors? This question unfortunately
remains open, but Jayaprakasan and colleagues have provided an important contribution to this field of research and
have, hopefully, stimulated others for further investigation. Consistency in findings observed by other IVF groups in
other industrialised countries with different samples would certainly fortify the concept of causality in this context.
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